(Headquarters: Tokyo, CEO: Haruo Naito, Eisai) announced today that the amyotrophic lateral sclerosis (ALS) treatment Rozebalamin for Injection 25 mg (mecobalamin) has been launched in Japan as a treatment for slowing progression of functional impairment in amyotrophic lateral sclerosis
TB-500 adds systemic support for more serious or chronic conditions
Involvement of hormone-and ROS-signaling pathways in the beneficial action of humic substances on plants growing under normal and stressing conditions
Unlike standard treatments like lifestyle changes and medications that target only one pathway, these innovative drugs aim to provide more robust weight management options
PQQ (Pyrroloquinoline Quinone) is a nutrient in cells, soil, food, and even breast milk
How much time is typically required for Glutathione to brighten skin